Keeping you up to date on recent developments in oncology, including: New nanoparticle could overcome aggregation-caused quenching for cancer treatment; Epigenetic resistance to PARP inhibitors; Statins help pancreatic tumors go from bad to worse; Sit up straight: PBT coming to a chair near you.
Keeping you up to date on recent developments in neurology, including: Putting virtual rehab for stroke patients to the test; Deep learning tool advances study of neural degeneration; Popular opinion correct on fear, anxiety.
Researchers at the University of Virginia have used a retrospective database analysis to show that the use of nucleoside reverse transcriptase inhibitors for the treatment of HIV or hepatitis B reduced the risk of developing type 2 diabetes by 33%.
BioWorld looks at translational medicine, including: Buyer beware for SARS-CoV-2 antibody detection; Statins help pancreatic tumors go from bad to worse.
Australia is famous, among other things, for venomous animals. Its plants, it turns out, are just as hostile. Now, researchers at the University of Queensland have isolated “neurotoxic peptides from the venom of the giant Australian stinging tree,” as they titled their paper. While the tree’s venomous effects were no secret – the authors wrote that it is known for its “remarkably persistent and painful stings upon contact,” which can produce pain flares for weeks – the effect had been attributed to small molecules.
Keeping you up to date on recent developments in oncology, including: Single-cell RNA sequencing may clarify response to chemotherapy; Epigenetic resistance to PARP inhibitors; Researchers eye organ-on-a-chip drug screening model.
BioWorld looks at translational medicine, including: Epigenetic resistance to PARP inhibitors; Arthritis is different disease with antibodies than without.
